- Home
- CEAD vs GTBP Comparison
CEAD vs GTBP Comparison
Compare CEAD & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEAD
- GTBP
- Stock Information
- Founded
- CEAD 2009
- GTBP 1965
- Country
- CEAD United States
- GTBP United States
- Employees
- CEAD N/A
- GTBP N/A
- Industry
- CEAD Industrial Machinery/Components
- GTBP Biotechnology: Pharmaceutical Preparations
- Sector
- CEAD Industrials
- GTBP Health Care
- Exchange
- CEAD Nasdaq
- GTBP Nasdaq
- Market Cap
- CEAD 5.6M
- GTBP 6.6M
- IPO Year
- CEAD N/A
- GTBP N/A
- Fundamental
- Price
- CEAD $6.00
- GTBP $3.06
- Analyst Decision
- CEAD
- GTBP
- Analyst Count
- CEAD 0
- GTBP 0
- Target Price
- CEAD N/A
- GTBP N/A
- AVG Volume (30 Days)
- CEAD 10.5K
- GTBP 21.7K
- Earning Date
- CEAD 11-14-2024
- GTBP 11-14-2024
- Dividend Yield
- CEAD N/A
- GTBP N/A
- EPS Growth
- CEAD N/A
- GTBP N/A
- EPS
- CEAD N/A
- GTBP N/A
- Revenue
- CEAD $2,637,116.00
- GTBP N/A
- Revenue This Year
- CEAD N/A
- GTBP N/A
- Revenue Next Year
- CEAD N/A
- GTBP N/A
- P/E Ratio
- CEAD N/A
- GTBP N/A
- Revenue Growth
- CEAD N/A
- GTBP N/A
- 52 Week Low
- CEAD $5.22
- GTBP $1.92
- 52 Week High
- CEAD $11.04
- GTBP $10.66
- Technical
- Relative Strength Index (RSI)
- CEAD 30.79
- GTBP 55.00
- Support Level
- CEAD $5.60
- GTBP $2.73
- Resistance Level
- CEAD $6.61
- GTBP $3.20
- Average True Range (ATR)
- CEAD 0.31
- GTBP 0.35
- MACD
- CEAD -0.09
- GTBP -0.04
- Stochastic Oscillator
- CEAD 26.44
- GTBP 42.65
About CEAD CEA Industries Inc.
CEA Industries Inc through its subsidiary is focused on selling environmental control and other technologies and services to the Controlled Environment Agriculture ("CEA") industry. The company provides integrated mechanical, electrical, and plumbing ("MEP") engineering design, proprietary and curated environmental control equipment, and automation offerings that serve the CEA industry. The Company has one operating segment that is dedicated to the manufacture and sale of its products.
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.